Q301--VA Boise, Idaho - Blood Bank Reagents Requirement

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

260-NETWORK CONTRACT OFFICE 20 (36C260)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26027Q0082

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

Q301

Additional Details
Set Aside

None

Place of Performance

Vancouver, WA, UNITED STATES

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its 260-Network Contract Office 20, has issued a presolicitation notice for the procurement of blood bank reagents to support operations at its facility in Vancouver, Washington. This requirement, identified under procurement number 36C26027Q0082, seeks to ensure the reliable supply of in-vitro diagnostic substances essential for blood bank testing and related laboratory services. The primary objective of this procurement is to secure high-quality blood bank reagents that meet the rigorous standards necessary for accurate and safe diagnostic testing within the VA healthcare system. These reagents are critical components in the detection, identification, and compatibility testing of blood samples, directly supporting patient care and transfusion safety for veterans served by the Vancouver, WA facility. The scope of this requirement encompasses the manufacturing and timely delivery of in-vitro diagnostic substances, as classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing, 2022 version). Contractors must demonstrate the capability to consistently supply reagents that adhere to all applicable regulatory and quality standards for medical laboratory use. While the specific types and quantities of reagents required are not detailed in this notice, interested vendors should be prepared to provide a comprehensive range of blood bank reagents suitable for routine and specialized testing protocols. The procurement is being managed by the 260-Network Contract Office 20, a federal office within the Department of Veterans Affairs. The designated point of contact for this opportunity is Andrew O'Neal, who can be reached via email at Andrew.O'[email protected] or by phone at 360-852-9861 for further information or clarification regarding the solicitation. This notice is classified under Product Service Code Q301, indicating its focus on medical laboratory testing and supplies. The place of performance is specified as Vancouver, Washington, United States. As a presolicitation notice, this announcement serves to inform potential offerors of the upcoming opportunity and to allow interested parties to prepare for the formal solicitation process. Contractors with experience in the manufacturing and supply of in-vitro diagnostic substances, particularly those with a proven track record in supporting healthcare or government laboratory environments, are encouraged to monitor this opportunity closely. No set-aside requirements or special considerations are specified in the current notice. Contractors should review the forthcoming solicitation documents for detailed requirements, evaluation criteria, and submission instructions once they become available. The notice remains active, with a response deadline set for October 26, 2026. Interested parties are advised to consult the official SAM.gov listing (Opportunity ID: 4ac72abae9d644a7a23e6d1e4a015ce7) for updates, attachments, and additional information as it is released. In summary, this procurement represents a significant opportunity for qualified vendors to support the VA’s mission of delivering high-quality healthcare to veterans by ensuring the availability of essential blood bank reagents at the Vancouver, WA facility.